Rare Disease Day 2021
Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients’ lives.
FARA & rideataxia
Meet Dr. Byrne and the team at the University of Florida! In this video, you will meet Dr. Byrne who will introduce you to their hardworking and dynamic team at the University of Florida. Do you spot anyone familiar? #rideATAXIAGlobalChallenge
Join us as we combine our SoCal and Gainesville communities for the first time ever to bring you the rideATAXIA Coastal Challenge! Together, we will raise funds and awareness for Friedreich’s ataxia (FA) research while challenging ourselves to stay active and bring the heat to the competition.
Clinical Research Center
A clinical trial is a research study that looks into the safety and usefulness of a drug in improving symptoms or slowing, stopping, or reversing the progression of a disease. Most drugs tested in clinical trials are not yet available to the public (Phase I, II, III studies) while some studies involve medications that are already available (Phase IV studies).
FLORIDA PHYSICIAN FEATURES
UF researchers’ groundbreaking work from 1980s leads to new treatment for debilitating neuromuscular disease
Dr. Barry Byrne has a unique ability to inspire others as he fights for his patients’ lives
UF performs first diaphragm pacing surgery on a patient with Pompe disease
The Fox family not only found a new home in Gainesville, they found new hope.
Pediatric Neuromuscular Clinic
The pediatric neuromuscular program at UF Health Shands Hospital offers one-stop access to comprehensive care, including leading-edge diagnostic techniques, medical treatments and research. Our neuromuscular program cares for infants, children and teens with neuromuscular disorders.
Dr. Barry Byrne is the Associate Chair of Pediatrics and Director of the Powell Gene Therapy Center. He obtained his B.S. degree from Denison University, his M.D. and Ph.D. from the University of Illinois. He completed his Pediatrics residency, cardiology fellowship training and post-doctoral training in Biological Chemistry at the Johns Hopkins Hospital. He joined the University of Florida in 1997 and is now the Earl and Christy Powell University Chair in Genetics.
Our research team conduct various clinical trials, working to identify improved therapies. As a result of this research, our patients are among the first to benefit from new discoveries.
Management of neuromuscular disorders requires multidisciplinary expertise. The pediatric neuromuscular program at UF Health Shands Hospital offers one-stop access to comprehensive care, including leading-edge diagnostic techniques, medical treatments and research.
Consistent and frequent neuromuscular rehabilitation is one of the few treatments, at this time, for all with a neuromuscular disease. It’s important through all stages and ages to potentially delay progression of the disease.
Headquartered in the greater Boston area, AavantiBio is co-founded by renowned gene therapy researchers Barry Byrne, M.D., Ph.D., and Manuela Corti, P.T., Ph.D., who together bring thirty years of experience to the Company.
Sarepta Therapeutics Inc., the leader in precision genetic medicine for rare diseases, and the University of Florida today announced a strategic collaboration to enable cutting-edge research for novel genetic medicines. Through the agreement, Sarepta will fund multiple research programs at the University, and will have an exclusive option to further develop any new therapeutic compounds that result from the funded research programs.
As the beginning of the school year quickly approaches, PPMD is working to support your family and help you plan for a successful classroom experience, whether it be in-person or virtual.
This MDCRC is organized around the concept that limiting fibrosis in the muscular dystrophies.